Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL.

Conclusion and Relevance: Based on our findings, the device thrombosis rate was 2% and the rate of major bleeding (BARC 3a and higher) was 35%. This study provides descriptive outcomes data of a lower-concentration heparin purge solution.
PMID: 32741200 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - July 31, 2020 Category: Drugs & Pharmacology Authors: Jiang C, Stuart M, Makowski C, Jennings DL, To L Tags: Ann Pharmacother Source Type: research